Company Current Liabilities: Progyny Inc (PGNY)

PGNY (progyny.com) - company brandmark

Progyny, Inc. (PGNY) margins rely on corporate IT budgets and the volume of insured individuals, while its narrow specialization in the reproductive health niche is offset by market leadership and long-term contracts. The asset's market value, which stands at 0.01 as illustrated on this chart, serves as an indicator of stability. Business growth is driven by the trend toward delayed parenthood, the expansion of women's healthcare services, and the corporate war for talent.

PGNY progyny.com Company Current Liabilities (07/04/2022 - 11/01/2026)
Mass-produced product of progyny.com

Searching for fundamentally resilient assets requires strict control over current liquidity. This indicator measures the aggregate of all liabilities maturing within one year, determining a business's ability to service its debts without the emergency sale of assets. For Progyny, Inc. (PGNY), this parameter is critical amid the risk of losing major corporate contracts or a decline in demand for reproductive services. An optimal balance of borrowed funds prevents developmental stagnation. By analyzing short-term loan capital, an investor assesses the operator's financial flexibility under regulatory pressure.

Key competitors

HCA Holdings - Company Short-Term Debts|THC - Company Short-Term Debts|FMS (Fresenius Medical Care Corp) - Company Current Liabilities|SOLV: Amount of Current Liabilities|Company Short-Term Debt Encompass Health|Company Current Liabilities Universal Health Services Corp (UHS)|Company Short-Term Debts DVA|RDNT - Short-Term Debt|Company Short-Term Debt Option Care Health Inc OPCH|SGRY: Company Short-Term Indebtedness|PINC: Company Current Liabilities|nationalvision.com - Amount of Current Liabilities|Ardent Health Partners (ARDT) - Company Short-Term Debt|Current Liabilities SEM (Select Medical Corporation)|Company Short-Term Debt Apollo Medical Holdings|MD: Company Short-Term Loans and Borrowings|Company Short-Term Debt U.S. Physical Therapy (USPH)|PNTG - Short-Term Debt|Company Short-Term Debts ORGO (Organogenesis)|Short-Term Indebtedness Nutex Health Inc|AUNA: Company Current Liabilities|Short-Term Debt SBC Medical Group Holdings Inc|Evolus, Inc. (EOLS) - Company Short-Term Debt|Company Short-Term Indebtedness CYH|Company Current Liabilities SKIN|Short-Term Debt MediWound, Ltd. MDWD|Company Current Liabilities BTMD (Biote Corp)|JYNT (The Joint) - Company Short-Term Loans and Borrowings|Company Short-Term Debts DCGO (DocGo Inc.)|Short-Term Debt Volume P3 Health Partners, Inc. (PIII)|GANX - Company Short-Term Debt|EUDA (euda.com) - Company Short-Term Indebtedness|BMGL: Company Short-Term Debts|Company Current Liabilities CollPlant Biotechnologies Ltd.|Company Current Liabilities CUPR|concordmedical.com (CCM) - Short-Term Debt Volume|Company Short-Term Debt American Shared Hospital Services (AMS)|MRM: Current Liabilities|Company Short-Term Debts ALBT (Avalon GloboCare Corp.)|Short-Term Indebtedness DIH Group|XAGE - Company Short-Term Debt|NIVF (newgenivf.com) - Company Short-Term Indebtedness|ATIP (atipt.com) - Company Current Liabilities|Short-Term Debt CareMax Inc. (CMAX)|Company Current Liabilities KDLY|MODV (ModivCare Corp) - Amount of Current Liabilities|Company Short-Term Debt Novo Integrated Sciences (NVOS)|SSY (sunlinkhealth.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BACK (IMAC Holdings)